Lactose (India) Ltd.
| BSE: 524202 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE058I01013 |
| BSE 00:00 | 27 Sep | 38.40 |
-2.45 (-6.00%) |
OPEN
40.45 |
HIGH
41.00 |
LOW
37.55 |
| NSE 05:30 | 01 Jan | Lactose (India) Ltd |
| OPEN | 40.45 |
| PREVIOUS CLOSE | 40.85 |
| VOLUME | 8743 |
| 52-Week high | 48.60 |
| 52-Week low | 16.20 |
| P/E | |
| Mkt Cap.(Rs cr) | 44 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Lactose (India) Ltd. (LACTOSEINDIA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 722.15 | 0.05 | 0.01 | 15823.68 |
| Cipla | 962.35 | -4.65 | -0.48 | 13900.58 |
| Dr Reddy's Labs | 4788.75 | -4.05 | -0.08 | 13349.10 |
| Sun Pharma.Inds. | 762.95 | -6.75 | -0.88 | 12803.21 |
| Lupin | 936.35 | 10.15 | 1.10 | 11055.93 |
| Apollo Hospitals | 4565.75 | -166.70 | -3.52 | 9153.00 |
| Cadila Health. | 557.10 | -7.65 | -1.35 | 7790.40 |
| Glenmark Pharma. | 503.75 | -3.90 | -0.77 | 7567.93 |
| Alkem Lab | 4000.65 | -1.20 | -0.03 | 7219.68 |
| Divi's Lab. | 4933.50 | -168.30 | -3.30 | 6798.61 |
| Torrent Pharma. | 3089.10 | -11.15 | -0.36 | 6450.83 |
| Ipca Labs. | 2372.35 | -29.75 | -1.24 | 5114.11 |
| Alembic Pharma | 788.65 | -3.10 | -0.39 | 5051.44 |
| Laurus Labs | 599.75 | -10.05 | -1.65 | 4768.72 |
| Abbott India | 21178.65 | -10.50 | -0.05 | 4310.02 |
| Gland Pharma | 3845.20 | -2.20 | -0.06 | 3462.88 |
| Glaxosmi. Pharma | 1489.20 | -9.30 | -0.62 | 3193.74 |
| Granules India | 319.10 | -2.35 | -0.73 | 3134.98 |
| Sanofi India | 7950.40 | -128.65 | -1.59 | 2901.90 |
| Ajanta Pharma | 2178.35 | 5.35 | 0.25 | 2718.59 |
Quick Links for Lactose (India):
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
